• English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
Morgan Stanley (MS.N) rose 2.6%.Sources say SpaceX is in talks with banks about an IPO, with Morgan Stanley being a leading candidate. Morgan Stanley, JPMorgan Chase, and Goldman Sachs are among the banks pitching their services to SpaceX.December 20th - According to the Washington Post, four people familiar with the upcoming announcement revealed that at least seven pharmaceutical companies will announce price reductions with President Trump at the White House on Friday. These include GlaxoSmithKline (GSK.N), Merck (MRK.N), and Sanofi (SNY.O). These companies will offer drug discounts to the government and the American public through a new website, TrumpRx.gov, in exchange for tariff reductions and other incentives, including expedited FDA approval processes for future drugs. White House Press Secretary Levitt stated on X that the drug price reduction announcement is imminent. This announcement follows a similar agreement reached by five companies previously, dating back to September when Pfizer CEO Albert Bourla announced price reductions with Trump. Since then, other pharmaceutical executives have joined in, announcing discounts on various products. In return, the government withdrew its threat of tariffs and offered other benefits, such as priority review vouchers to expedite FDA approvals (which could potentially earn companies hundreds of millions of dollars more if new drugs are approved quickly).Market news: Several pharmaceutical companies, including GlaxoSmithKline (GSK.N) and Sanofi (SNY.O), are planning to announce price reductions.U.S. Secretary of State Marco Rubio: A peace agreement is impossible unless Ukraine also agrees.

S&P 500 Price Forecast – Stock Markets Give Up Yet Again

Skylar Shaw

May 19, 2022 10:47

微信截图_20220519100619.png


Technical Analysis of the S&P 500

Futures on the S&P 500 have rolled over just below the 4100 level, a place that I have been discussing for many days. This is a previously supported location, and "market memory" enters the picture to provide resistance. That resistance should continue all the way to 4150, but as you can see, we've plummeted before even trying a breakthrough. By plunging the way we have, it seems that there are still many worries in the stock market. It is also worth mentioning that Target indicated a slowdown during its results call. Many individuals are concerned about the US consumer, and as a result, there has been a lot of hostility.


If we turn around a break above the 4150 level, there is still a lot of resistance that stretches all the way to the 4300 zone, so I'm not looking to purchase this anytime soon. In fact, I believe we will test the lows once again, which are closer to the 3850 level. If we break down below that level, the fall will very certainly accelerate. I think that the prospect of the Federal Reserve failing to intervene is now dawning on some of Wall Street's thick heads, and this is reflected in the price.


Regardless, I have no intention of attempting to purchase this market any time soon since, quite honestly, it is a nightmare right now. The S&P 500 remains a "sell the rallies" position until the Federal Reserve changes its tune or economic data improves.